key: cord-0906316-kntehcv6
authors: Miller, Robert C.; Tsai, C. Jillian
title: Advances in Radiation Oncology in 2020
date: 2020-10-29
journal: Adv Radiat Oncol
DOI: 10.1016/j.adro.2020.09.014
sha: a7a126d083b33bac8770663aa4b12273f5b8643a
doc_id: 906316
cord_uid: kntehcv6

nan

the virus in their communities. The report from Novara, Italy by Kringle et al 3 has been one of the most read articles we have published and has already received 32 citations to date in the published literature, an unusually high number for a radiation oncology manuscript in print for just a little over 6 months. Also included in this issue are the recommendations by Zagorsky et al 4 for prostate cancer treatment, which has received 43 citations in even less time in print. These were published as a special edition in July of 2020. 5 Also included in this edition is the appeal by Winfield and colleagues 6, 7 for racial justice to be addressed in radiation oncology and a reply by DeWeese representing American Society for Radiation Oncology's viewpoint. Similar to the public repositories created by the major publisher for timely access to COVID-19, Elsevier created a central, open access collection of noteworthy papers addressing racial and social equality challenges in academia across all scientific disciplines, medical and nonmedical, in which Advances submissions were prominently highlighted. 8 Advances has seen significant growth in noneCOVID-19 related articles alongside the pandemic-related submissions. Several of our most popular noneCOVID-19 related papers are also included in this special edition. Figure 2 illustrates the growth in accepted manuscripts in Advances over the past year. Both COVID-19 and noneCOVID-19 related submissions grew significantly in 2020. The editorial board of Advances continues to focus on speed of evaluation of manuscripts and reducing time from acceptance to online publication. Manuscripts are assigned handling editors on average within 1 day after submission processing. Time to first decision is currently about 30 days. Time from acceptance to appearing online in draft form is 2 weeks. In response to author feedback, Advances will shift to article-based publishing in 2021, which will shorten the time to indexing of our articles, which will now occur when they are published in final pdf form.

The unique challenges in disseminating scientific knowledge during the pandemic have accelerated the shift toward open science that will require flexibility in academic publishing to meet the needs of our authors and readers. As an open access journal, always freely available globally to researchers, doctors, and our patients, Advances is well positioned to adapt to these coming changes in incorporation of preprints into the publication cycles, online post publication peer review/ commentaries, and other novel innovations in 2021. 

The international response to the coronavirus disease (2019) COVID-19 pandemic in radiation oncology

Running a radiation oncology department at the time of coronavirus: An Italian experience

Prostate cancer radiation therapy recommendations in response to COVID-19

Radiation oncology and COVID-19. Available at

Why racial justice matters in radiation oncology

Confronting racism in radiation oncology: Now is the time and today is the day

The Elsevier Community. Working toward racial and social equality: Research and commentary